March 9, 2022: Dr. Certina Ho recognized by the Leslie Dan Faculty of Pharmacy with the Leadership in Pharmacy Practice Award
Congratulations to Certina Ho, an integral member of the ISMP Canada leadership team, who has been recognized by the Leslie Dan Faculty of Pharmacy as an exceptional alumnus. Certina is the deserving recipient of the Leadership in Pharmacy Practice Award. For more information: https://www.pharmacy.utoronto.ca/news-announcements/exceptional-alumni-recognized-through-second-annual-alumni-awards
November 24, 2021: NEWS RELEASE - Announcing 10 Champion Homes for the Ontario Strengthening Medication Safety in Long-Term Care Initiative
Ontario Strengthening Medication Safety in Long-Term Care Initiative
The Institute for Safe Medication Practices Canada (ISMP Canada) is partnering with 10 Champion long-term care homes in Ontario to improve medication safety and help address recommendations from the Justice Gillese Public Inquiry report. This initiative is funded by the Ministry of Long-Term Care and is designed to improve medication safety by providing support (tools, education and coaching) to homes. Read more ...
September 29, 2021: Safety Bulletin - Call for Shared Learning with Virtual Care Experiences
ISMP Canada, in partnership with Healthcare Excellence Canada, is working to advance safety in virtual care. We are exploring medication safety concerns, facilitators, and barriers. Help turn your experiences into system-based improvements by sharing your virtual care-related medication incidents with ISMP Canada. Read more ...May 11, 2021: ISMP Canada and iMD Health Global announce partnership to provide further information for prevention of harmful medication errors across Canada
The Institute for Safe Medication Practices Canada (ISMP Canada) is pleased to jointly announce an important partnership with iMD Health Global (a CloudMD Software & Services company) to support education and increase awareness of the risks associated with medication errors. Information and tools to prevent harmful medication errors to Canadians will be shared via the iMD platform. Read more ... March 9, 2021: Career Opportunity: Part-Time Project Manager
.:Canada's National Incident Data Repository for Community Pharmacies
ISMP Canada established a national incident data repository for community pharmacies through its community pharmacy incident reporting program. Community pharmacies in several provinces are already contributing to this national repository for continuous quality improvement, and pharmacies in other provinces are considering participation in this effort as well. The repository is helping to create a more cohesive information-sharing system that will facilitate better understanding of medication incidents and the development of more robust strategies to prevent harm. Read more ...
.: Educational Support for Mandatory Reporting of Serious Adverse Drug Reactions and Medical Device Incidents
It will be mandatory for hospitals to report serious adverse drug reactions (serious ADRs) and medical device incidents (MDIs) to Health Canada, effective December 16, 2019. Four PowerPoint modules can be used (as entire modules or selected content) by hospitals, health care professionals, and educators, to explain, describe, or promote the reporting of serious ADRs and MDIs. Patients for Patient Safety Canada created an additional PowerPoint module to help patients and the public understand and promote the reporting of serious adverse drug reactions and medical device incidents. Read more ...
Related ISMP Canada Resources:
• December 12, 2019: ISMP Canada Safety Bulletin Educational Support for Mandatory Reporting of Serious ADRs and MDIs by Hospitals
• August 21, 2019: SafeMedicationUse.ca Consumer Newsletter Protecting Canadians from Unsafe Drugs Act - What It Means for You
• July 31, 2019: ISMP Canada Safety Bulletin Educational Support for Mandatory Reporting of Serious Adverse Drug Reactions and Medical Device Incidents
• July 17, 2019: Med Safety Exchange webinar Educational Support for Mandatory Reporting of Serious ADRs and MDIs
